FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055397 [Registered on: 20/07/2023] Trial Registered Prospectively
Last Modified On: 14/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Other 
Public Title of Study   Gene Polymoprhism of a novel Biomarker in Symptomatic Irreversible Pulpitis and Chronic Apical Periodontitis  
Scientific Title of Study   Association of NLRP3 single nucleotide  polymorphism in gingival crevicular fluid of patients diagnosed with Symptomatic Irreversible Pulpitis & Chronic Apical Periodontitis in a section of the North Indian population – A case-control study ​ 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Saumya Verma 
Designation  post graduate student 
Affiliation  Manav Rachna Dental College 
Address  Room number 7 department of conservative dentistry and endodonticsnManav Rachna Dental College Sector 43 Delhi Suraj Kund Badkhal Rd Faridabad
Room number 7 department of conservative dentistry and endodonticsnManav Rachna Dental College Sector 43 Delhi Suraj Kund Badkhal Rd Faridabad
Faridabad
HARYANA
121004
India 
Phone  9724187569  
Fax    
Email  saumya.mrdc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dax Abraham 
Designation  Professor and head of department 
Affiliation  Manav Rachna Dental College 
Address  Department of conservative dentistry, room no.7, second floor, Manav Rachna Dental College Sector 43 Delhi Suraj Kund Badkhal Rd Faridabad
Department of conservative dentistry, room no.7, second floor, Manav Rachna Dental College Sector 43 Delhi Suraj Kund Badkhal Rd Faridabad
Faridabad
HARYANA
121004
India 
Phone  9910433111  
Fax    
Email  daxabraham.mrdc@mrei.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dax Abraham 
Designation  Professor and head of department 
Affiliation  Manav Rachna Dental College 
Address  Department of conservative dentistry, room no.7, second floor, Manav Rachna Dental College Sector 43 Delhi Suraj Kund Badkhal Rd Faridabad
Department of conservative dentistry, room no.7, second floor, Manav Rachna Dental College Sector 43 Delhi Suraj Kund Badkhal Rd Faridabad
Faridabad
HARYANA
121004
India 
Phone  9910433111  
Fax    
Email  daxabraham.mrdc@mrei.ac.in  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Saumya Verma 
Address  Manav Rachna Dental College Sector 43 Delhi Suraj Kund Badkhal Rd Faridabad 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dax Abraham  Manav Rachna dental college  Department of conservative dentistry, room no.7, second floor, Manav Rachna Dental College Sector 43 Delhi Suraj Kund Badkhal Rd Faridabad
Faridabad
HARYANA 
9910433111

daxabraham.mrdc@mrei.ac 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Manav Rachna Dental College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K045||Chronic apical periodontitis, (2) ICD-10 Condition: K040||Pulpitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  Patients diagnosed with symptomatic irreversible pulpitis according to AAE guidelines.
Patients diagnosed with chronic apical periodontitis according to AAE guidelines
Patients with no relevant history and systemic diseases.

 
 
ExclusionCriteria 
Details  Patients with multiple carious teeth.
Patients with any systemic condition. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Single nucleotide polymorphism of NLRP3 gene is sought to be detected   1 year 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment of levels of NLRP3 levels in SIP patients, CAP patients & healthy controls.   1 year 6 months 
 
Target Sample Size   Total Sample Size="48"
Sample Size from India="48" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study aims to investigate the potential association between NLRP3 single nucleotide polymorphism (SNP) and the occurrence of symptomatic irreversible pulpitis (SIP) and chronic apical periodontitis (CAP) in a section of the North Indian population. The study will be a case-control study in which participants diagnosed with SIP and CAP will be compared to healthy controls. Gingival crevicular fluid (GCF) samples will be collected from all participants, and NLRP3 SNPs will be analyzed using PCR-based genotyping. The rationale behind this study is that previous research has shown that NLRP3 inflammasome activation plays a critical role in the initiation and progression of inflammatory diseases, including SIP and CAP. Moreover, it has been suggested that NLRP3 SNPs may be associated with the development and severity of these diseases. However, no studies have investigated the potential relationship between NLRP3 SNPs and SIP and CAP in the North Indian population. The study will recruit a total of 48 participants, including 16 patients diagnosed with SIP, 16 patients diagnosed with CAP, and 16 healthy controls. The inclusion criteria for the patients will be based on standard clinical and radiographic criteria, while the exclusion criteria will include the presence of any systemic disease. All participants will be asked to sign an informed consent form. Phenotyping will be done to maintain participant confidentiality, and data will be stored securely. Statistical analysis will be performed to assess the association between NLRP3 SNPs and SIP and CAP. The results of this study may have important clinical implications, as the analysis of NLRP3 SNPs in GCF could potentially serve as a non-invasive diagnostic marker for SIP and CAP. In summary, this case-control study aims to investigate the potential association between NLRP3 SNPs and the occurrence of SIP and CAP in a section of the North Indian population. The results of this study may contribute to our understanding of the pathogenesis of these diseases and may have important clinical implications for the diagnosis and treatment of SIP and CAP.

 
Close